The Peptide Synthesis market valued at US$ 0.78 Billion in 2023, is forecasted to grow at a robust CAGR of 11.7%, reaching US$ 0.81 Billion in ...

Faced with the encroaching threats of patent expirations and generics, biopharma companies in 2024 invested 33% more in licensing deals, on average, than in 2023 with an eye toward enriching their ...

In this manuscript the authors established a novel three-dimensional culture system for stratified epithelia that allows epithelial cells to undergo epithelial-to-mesenchymal transition (EMT) and ...

Microbix Biosystems Inc. , a life sciences innovator, manufacturer, and exporter, announces that it expects to file the financial statements and management disclosure and analysis for its first ...

A microbioreactor is a way of “doing more with less” succinctly stated Wei-Xiang Sin, PhD, research scientist at SMART CAMP. As these tiny growth machines become even more sophisticated with machine ...

Microbix Biosystems Inc. , a life sciences innovator, manufacturer, and exporter, announces that it has received C$ 2.4 million in new equity capital from the partial exercise of expiring share ...

The vanillin market focuses on the production and distribution of vanillin, a key flavoring agent widely used in the food, beverage, and fragrance industries. Derived from natural sources like vanilla ...

The next-generation sequencing market valued at US$ 13.92 billion in 2023, is forecasted to grow at a robust CAGR of 11.0%, reaching US$ 13.28 ...

Merck traces its history back to 1668 ... Among other things, the company produces reagents and drugs, including for treating cancers and depression. Roche is also an old and established company ...